Clinical Trials · NCT02340819

Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Teduglutide in Japanese Subjects With PN-dependent Short Bowel Syndrome (SBS)

Name: Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Teduglutide in Japanese Subjects With PN-dependent Short Bowel Syndrome (SBS)
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 3Teduglutide

Phase: Phase 3
Recruitment status: Completed
Sponsor: Shire
Enrollment: 11
Start date: Dec 2014
Locations: 5 sites, Japan
Primary endpoint: Stage 2: Absolute Change From Baseline in Weekly Parenteral Support (PS) Volume at Week 24

View Teduglutide compound reference